Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Teva's CGRP Migraine Med Hits a Stumbling Block February 8, 2018 Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 December 11, 2017 Integra LifeSciences Launches Revize/ Revize-X Collagen Matrix For Plastic And Reconstructive Surgery October 5, 2017
Integra LifeSciences Launches Revize/ Revize-X Collagen Matrix For Plastic And Reconstructive Surgery October 5, 2017
